Striatal dopamine D2/D3 receptor binding in pathological gambling is correlated with mood-related impulsivity

NeuroImage

Volumn 63, Issue 1, 2012, Pages 40-46

  Clark, Luke ^a   Stokes, Paul R ^b   Wu, Kit ^b   Michalczuk, Rosanna ^a   Benecke, Aaf ^b   Watson, Ben J ^c   Egerton, Alice ^d   Piccini, Paola ^b   Nutt, David J ^b   Bowden Jones, Henrietta ^b,e   Lingford Hughes, Anne R ^b,e  

^a UK   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e CENTRAL AND NORTH WEST LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Addiction; Dopamine; Gambling; Impulsivity; Neuroimaging; Striatum

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; RACLOPRIDE C 11;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; IMPULSIVENESS; MALE; MOOD; PATHOLOGICAL GAMBLING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; RECEPTOR BINDING; UPPS P IMPULSIVE BEHAVIOR SCALE;

ADULT; AFFECT; CORPUS STRIATUM; FEMALE; GAMBLING; HUMANS; IMPULSIVE BEHAVIOR; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; STATISTICS AS TOPIC;

EID: 84864418521     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2012.06.067     Document Type: Article

References (59)

1. Backman L., Ginovart N., Dixon R.A., Wahlin T.B., Wahlin A., Halldin C., Farde L. Age-related cognitive deficits mediated by changes in the striatal dopamine system. Am. J. Psychiatry 2000, 157:635-637.
2. Bergh C., Eklund T., Sodersten P., Nordin C. Altered dopamine function in pathological gambling. Psychol. Med. 1997, 27:473-475.
3. Blaszczynski A., Nower L. A pathways model of problem and pathological gambling. Addiction 2002, 97:487-499.
4. Bowden-Jones H., Clark L. Pathological Gambling: a neurobiological and clinical update. Br. J. Psychiatry 2011, 199:87-89.
5. Boy F., Evans C.J., Edden R.A., Lawrence A.D., Singh K.D., Husain M., Sumner P. Dorsolateral prefrontal gamma-aminobutyric acid in men predicts individual differences in rash impulsivity. Biol. Psychiatry 2011, 70:866-872.
6. Buckholtz J.W., Treadway M.T., Cowan R.L., Woodward N.D., Li R., Ansari M.S., Baldwin R.M., Schwartzman A.N., Shelby E.S., Smith C.E., Kessler R.M., Zald D.H. Dopaminergic network differences in human impulsivity. Science 2010, 329:532.
7. Busto U.E., Redden L., Mayberg H., Kapur S., Houle S., Zawertailo L.A. Dopaminergic activity in depressed smokers: a positron emission tomography study. Synapse 2009, 63:681-689.
8. Carson R.E., Breier A., de Bartolomeis A., Saunders R.C., Su T.P., Schmall B., Der M.G., Pickar D., Eckelman W.C. Quantification of amphetamine-induced changes in [11C]raclopride binding with continuous infusion. J. Cereb. Blood Flow Metab. 1997, 17:437-447.
9. Chase H.W., Clark L. Gambling severity predicts midbrain response to near-miss outcomes. J. Neurosci. 2010, 30:6180-6187.
10. Cilia R., Ko J.H., Cho S.S., van Eimeren T., Marotta G., Pellecchia G., Pezzoli G., Antonini A., Strafella A.P. Reduced dopamine transporter density in the ventral striatum of patients with Parkinson's disease and pathological gambling. Neurobiol. Dis. 2010, 39:98-104.
11. Cools R., D'Esposito M. Inverted-U-shaped dopamine actions on human working memory and cognitive control. Biol. Psychiatry 2011, 69:e113-e125.
12. Cyders M.A., Smith G.T. Emotion-based dispositions to rash action: positive and negative urgency. Psychol. Bull. 2008, 134:807-828.
13. Cyders M.A., Smith G.T., Spillane N.S., Fischer S., Annus A.M., Peterson C. Integration of impulsivity and positive mood to predict risky behavior: development and validation of a measure of positive urgency. Psychol. Assess. 2007, 19:107-118.
14. Dalley J.W., Fryer T.D., Brichard L., Robinson E.S., Theobald D.E., Laane K., Pena Y., Murphy E.R., Shah Y., Probst K., Abakumova I., Aigbirhio F.I., Richards H.K., Hong Y., Baron J.C., Everitt B.J., Robbins T.W. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 2007, 315:1267-1270.
15. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl. Acad. Sci. U. S. A. 1988, 85:5274-5278.
16. Egerton A., Mehta M.A., Montgomery A.J., Lappin J.M., Howes O.D., Reeves S.J., Cunningham V.J., Grasby P.M. The dopaminergic basis of human behaviors: a review of molecular imaging studies. Neurosci. Biobehav. Rev. 2009, 33:1109-1132.
17. Egerton A., Shotbolt J.P., Stokes P.R., Hirani E., Ahmad R., Lappin J.M., Reeves S.J., Mehta M.A., Howes O.D., Grasby P.M. Acute effect of the anti-addiction drug bupropion on extracellular dopamine concentrations in the human striatum: an [11C]raclopride PET study. Neuroimage 2010, 50:260-266.
18. Ersche K.D., Turton A.J., Pradhan S., Bullmore E.T., Robbins T.W. Drug addiction endophenotypes: impulsive versus sensation-seeking personality traits. Biol. Psychiatry 2010, 68:770-773.
19. Fehr C., Yakushev I., Hohmann N., Buchholz H.G., Landvogt C., Deckers H., Eberhardt A., Klager M., Smolka M.N., Scheurich A., Dielentheis T., Schmidt L.G., Rosch F., Bartenstein P., Grunder G., Schreckenberger M. Association of low striatal dopamine d2 receptor availability with nicotine dependence similar to that seen with other drugs of abuse. Am. J. Psychiatry 2008, 165:507-514.
20. Ferris J., Wynne H. Canadian Problem Gambling Index 2001, Canadian Centre on Substance Abuse, Ottawa, Ontario.
21. Fong T., Kalechstein A., Bernhard B., Rosenthal R., Rugle L. A double-blind, placebo-controlled trial of olanzapine for the treatment of video poker pathological gamblers. Pharmacol. Biochem. Behav. 2008, 89:298-303.
22. Frascella J., Potenza M.N., Brown L.L., Childress A.R. Shared brain vulnerabilities open the way for nonsubstance addictions: carving addiction at a new joint?. Ann. N. Y. Acad. Sci. 2010, 1187:294-315.
23. Gjedde A., Kumakura Y., Cumming P., Linnet J., Moller A. Inverted-U-shaped correlation between dopamine receptor availability in striatum and sensation seeking. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:3870-3875.
24. Heinz A., Siessmeier T., Wrase J., Hermann D., Klein S., Grusser S.M., Flor H., Braus D.F., Buchholz H.G., Grunder G., Schreckenberger M., Smolka M.N., Rosch F., Mann K., Bartenstein P. Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving. Am. J. Psychiatry 2004, 161:1783-1789.
25. Innis R.B., Cunningham V.J., Delforge J., Fujita M., Gjedde A., Gunn R.N., Holden J., Houle S., Huang S.C., Ichise M., Iida H., Ito H., Kimura Y., Koeppe R.A., Knudsen G.M., Knuuti J., Lammertsma A.A., Laruelle M., Logan J., Maguire R.P., Mintun M.A., Morris E.D., Parsey R., Price J.C., Slifstein M., Sossi V., Suhara T., Votaw J.R., Wong D.F., Carson R.E. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J. Cereb. Blood Flow Metab. 2007, 27:1533-1539.
26. Ito H., Hietala J., Blomqvist G., Halldin C., Farde L. Comparison of the transient equilibrium and continuous infusion method for quantitative PET analysis of [11C]raclopride binding. J. Cereb. Blood Flow Metab. 1998, 18:941-950.
27. Joutsa J., Johansson J., Niemela S., Ollikainen A., Hirvonen M.M., Piepponen P., Arponen E., Alho H., Voon V., Rinne J.O., Hietala J., Kaasinen V. Mesolimbic dopamine release is linked to symptom severity in pathological gambling. Neuroimage 2012, 60:1992-1999.
28. Kessler R.C., Hwang I., LaBrie R., Petukhova M., Sampson N.A., Winters K.C., Shaffer H.J. DSM-IV pathological gambling in the National Comorbidity Survey Replication. Psychol. Med. 2008, 38:1351-1360.
29. Kim J.H., Son Y.D., Kim H.K., Lee S.Y., Cho S.E., Kim Y.B., Cho Z.H. Effects of age on dopamine D(2) receptor availability in striatal subdivisions: A high-resolution positron emission tomography study. Eur. Neuropsychopharmacol. 2011, 21:885-891.
30. Lee B., London E.D., Poldrack R.A., Farahi J., Nacca A., Monterosso J.R., Mumford J.A., Bokarius A.V., Dahlbom M., Mukherjee J., Bilder R.M., Brody A.L., Mandelkern M.A. Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity. J. Neurosci. 2009, 29:14734-14740.
31. Leeman R.F., Potenza M.N. Similarities and differences between pathological gambling and substance use disorders: a focus on impulsivity and compulsivity. Psychopharmacology (Berl) 2012, 219:469-490.
32. Lesieur H.R., Blume S.B. The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers. Am. J. Psychiatry 1987, 144:1184-1188.
33. Linnet J., Moller A., Peterson E., Gjedde A., Doudet D. Dopamine release in ventral striatum during Iowa Gambling Task performance is associated with increased excitement levels in pathological gambling. Addiction 2011, 106:383-390.
34. Martinez D., Slifstein M., Broft A., Mawlawi O., Hwang D.R., Huang Y., Cooper T., Kegeles L., Zarahn E., Abi-Dargham A., Haber S.N., Laruelle M. Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum. J. Cereb. Blood Flow Metab. 2003, 23:285-300.
35. Martinez D., Broft A., Foltin R.W., Slifstein M., Hwang D.R., Huang Y., Perez A., Frankle W.G., Cooper T., Kleber H.D., Fischman M.W., Laruelle M. Cocaine dependence and d2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behavior. Neuropsychopharmacology 2004, 29:1190-1202.
36. Martinez D., Greene K., Broft A., Kumar D., Liu F., Narendran R., Slifstein M., Van Heertum R., Kleber H.D. Lower level of endogenous dopamine in patients with cocaine dependence: findings from PET imaging of D(2)/D(3) receptors following acute dopamine depletion. Am. J. Psychiatry 2009, 166:1170-1177.
37. Matsumoto M., Togashi H., Kaku A., Kanno M., Tahara K., Yoshioka M. Cortical GABAergic regulation of dopaminergic responses to psychological stress in the rat dorsolateral striatum. Synapse 2005, 56:117-121.
38. McElroy S.L., Nelson E.B., Welge J.A., Kaehler L., Keck P.E. Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trial. J. Clin. Psychiatry 2008, 69:433-440.
39. Meyer G., Schwertfeger J., Exton M.S., Janssen O.E., Knapp W., Stadler M.A., Schedlowski M., Kruger T.H. Neuroendocrine response to casino gambling in problem gamblers. Psychoneuroendocrinology 2004, 29:1272-1280.
40. Michalczuk R., Bowden-Jones H., Verdejo-Garcia A., Clark L. Impulsivity and cognitive distortions in pathological gamblers attending the UK National Problem Gambling Clinic: a preliminary report. Psychol. Med. 2011, 41:2625-2635.
41. Montgomery A.J., Thielemans K., Mehta M.A., Turkheimer F., Mustafovic S., Grasby P.M. Correction of head movement on PET studies: comparison of methods. J. Nucl. Med. 2006, 47:1936-1944.
42. Nader M.A., Morgan D., Gage H.D., Nader S.H., Calhoun T.L., Buchheimer N., Ehrenkaufer R., Mach R.H. PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys. Nat. Neurosci. 2006, 9:1050-1056.
43. O'Sullivan S.S., Wu K., Politis M., Lawrence A.D., Evans A.H., Bose S.K., Djamshidian A., Lees A.J., Piccini P. Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours. Brain 2011, 134:969-978.
44. Reuter J., Raedler T., Rose M., Hand I., Glascher J., Buchel C. Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat. Neurosci. 2005, 8:147-148.
45. Shaffer H.J., LaBrie R., Scanlan K.M., Cummings T.N. Pathological Gambling among adolescents: Massachusetts Gambling Screen (MAGS). J. Gambl. Stud. 1994, 10:339-362.
46. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 1998, 59(Suppl. 20):22-33.
47. Slutske W.S., Caspi A., Moffitt T.E., Poulton R. Personality and problem gambling: a prospective study of a birth cohort of young adults. Arch. Gen. Psychiatry 2005, 62:769-775.
48. Smith N., Kitchenham N., Bowden-Jones H. Pathological gambling and the treatment of psychosis with aripiprazole: case reports. Br. J. Psychiatry 2011, 199:158-159.
49. Steeves T.D., Miyasaki J., Zurowski M., Lang A.E., Pellecchia G., Van Eimeren T., Rusjan P., Houle S., Strafella A.P. Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain 2009, 132:1376-1385.
50. Stewart S.H., Zack M. Development and psychometric evaluation of a three-dimensional Gambling Motives Questionnaire. Addiction 2008, 103:1110-1117.
51. Stokes P.R., Egerton A., Watson B., Reid A., Breen G., Lingford-Hughes A., Nutt D.J., Mehta M.A. Significant decreases in frontal and temporal [11C]-raclopride binding after THC challenge. Neuroimage 2010, 52:1521-1527.
52. Verdejo-Garcia A., Lawrence A.J., Clark L. Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci. Biobehav. Rev. 2008, 32:777-810.
53. Volkow N.D., Wang G.J., Fowler J.S., Logan J., Gatley S.J., Hitzemann R., Chen A.D., Dewey S.L., Pappas N. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 1997, 386:830-833.
54. Volkow N.D., Wang G.J., Fowler J.S., Logan J., Gatley S.J., Gifford A., Hitzemann R., Ding Y.S., Pappas N. Prediction of reinforcing responses to psychostimulants in humans by brain dopamine D2 receptor levels. Am. J. Psychiatry 1999, 156:1440-1443.
55. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Ding Y.S., Sedler M., Logan J., Franceschi D., Gatley J., Hitzemann R., Gifford A., Wong C., Pappas N. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am. J. Psychiatry 2001, 158:2015-2021.
56. Voon V., Fernagut P.O., Wickens J., Baunez C., Rodriguez M., Pavon N., Juncos J.L., Obeso J.A., Bezard E. Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders. Lancet Neurol. 2009, 8:1140-1149.
57. Wang G.J., Volkow N.D., Logan J., Pappas N.R., Wong C.T., Zhu W., Netusil N., Fowler J.S. Brain dopamine and obesity. Lancet 2001, 357:354-357.
58. Watabe H., Endres C.J., Breier A., Schmall B., Eckelman W.C., Carson R.E. Measurement of dopamine release with continuous infusion of [11C]raclopride: optimization and signal-to-noise considerations. J. Nucl. Med. 2000, 41:522-530.
59. Zald D.H., Boileau I., El-Dearedy W., Gunn R., McGlone F., Dichter G.S., Dagher A. Dopamine transmission in the human striatum during monetary reward tasks. J. Neurosci. 2004, 24:4105-4112.